Compare SUVEN LIFE with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs CIPLA - Comparison Results

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES CIPLA SUVEN LIFESCIENCES/
CIPLA
 
P/E (TTM) x 18.0 23.4 76.9% View Chart
P/BV x 3.7 2.4 152.6% View Chart
Dividend Yield % 0.6 0.7 85.9%  

Financials

 SUVEN LIFESCIENCES   CIPLA
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
CIPLA
Mar-19
SUVEN LIFESCIENCES/
CIPLA
5-Yr Chart
Click to enlarge
High Rs338678 49.8%   
Low Rs169484 35.0%   
Sales per share (Unadj.) Rs52.1198.2 26.3%  
Earnings per share (Unadj.) Rs6.818.5 36.9%  
Cash flow per share (Unadj.) Rs8.635.0 24.5%  
Dividends per share (Unadj.) Rs1.503.00 50.0%  
Dividend yield (eoy) %0.60.5 114.6%  
Book value per share (Unadj.) Rs65.3186.3 35.0%  
Shares outstanding (eoy) m127.28805.70 15.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.92.9 166.0%   
Avg P/E ratio x37.131.4 118.4%  
P/CF ratio (eoy) x29.616.6 178.2%  
Price / Book Value ratio x3.93.1 124.6%  
Dividend payout %22.016.2 135.6%   
Avg Mkt Cap Rs m32,272468,031 6.9%   
No. of employees `0001.122.6 4.8%   
Total wages/salary Rs m66128,565 2.3%   
Avg. sales/employee Rs Th6,132.27,053.1 86.9%   
Avg. wages/employee Rs Th611.11,261.5 48.4%   
Avg. net profit/employee Rs Th803.5659.1 121.9%   
INCOME DATA
Net Sales Rs m6,635159,710 4.2%  
Other income Rs m2424,766 5.1%   
Total revenues Rs m6,877164,475 4.2%   
Gross profit Rs m1,60430,973 5.2%  
Depreciation Rs m22113,263 1.7%   
Interest Rs m381,684 2.2%   
Profit before tax Rs m1,58720,791 7.6%   
Minority Interest Rs m0-172 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7185,695 12.6%   
Profit after tax Rs m86914,924 5.8%  
Gross profit margin %24.219.4 124.7%  
Effective tax rate %45.227.4 165.1%   
Net profit margin %13.19.3 140.2%  
BALANCE SHEET DATA
Current assets Rs m6,232124,266 5.0%   
Current liabilities Rs m1,49037,715 4.0%   
Net working cap to sales %71.554.2 131.9%  
Current ratio x4.23.3 126.9%  
Inventory Days Days8691 95.4%  
Debtors Days Days8395 87.1%  
Net fixed assets Rs m4,043105,190 3.8%   
Share capital Rs m1271,611 7.9%   
"Free" reserves Rs m8,183148,511 5.5%   
Net worth Rs m8,310150,123 5.5%   
Long term debt Rs m1838,301 0.0%   
Total assets Rs m10,389239,633 4.3%  
Interest coverage x43.113.3 323.0%   
Debt to equity ratio x00.3 0.8%  
Sales to assets ratio x0.60.7 95.8%   
Return on assets %8.76.9 126.0%  
Return on equity %10.59.9 105.2%  
Return on capital %19.511.8 164.9%  
Exports to sales %034.7 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA55,419 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,62257,410 9.8%   
Fx outflow Rs m1,79919,041 9.5%   
Net fx Rs m3,82238,368 10.0%   
CASH FLOW
From Operations Rs m35616,911 2.1%  
From Investments Rs m-279-16,687 1.7%  
From Financial Activity Rs m-225-3,487 6.5%  
Net Cashflow Rs m-148-3,451 4.3%  

Share Holding

Indian Promoters % 63.4 16.0 396.3%  
Foreign collaborators % 0.0 20.8 -  
Indian inst/Mut Fund % 0.0 12.2 -  
FIIs % 0.0 23.7 -  
ADR/GDR % 0.0 1.1 -  
Free float % 36.5 26.2 139.3%  
Shareholders   37,287 161,166 23.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   WOCKHARDT  J.B.CHEMICALS  PROCTER & GAMBLE HEALTH  BIOCON   FULFORD INDIA  

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 93 Points Higher; Oil & Gas and Realty Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the oil & gas sector.

Related Views on News

CIPLA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

CIPLA Announces Quarterly Results (1QFY20); Net Profit Up 5.6% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CIPLA has posted a net profit of Rs 5 bn (up 5.6% YoY). Sales on the other hand came in at Rs 40 bn (up 1.3% YoY). Read on for a complete analysis of CIPLA's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Oct 16, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES - CADILA HEALTHCARE COMPARISON

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS